Biocept News 2020, (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to Biocept launches combined COVID-19 and influenza test to help patients and caregivers determine treatment decisions during peak flu season. 10, 2020 /PRNewswire/ -- Biocept, Inc. SAN DIEGO, Jan. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with SAN DIEGO, June 5, 2020 /PRNewswire/ -- Biocept, Inc. September 2020 bekannt. Für das dritte Quartal gab das Unternehmen einen Umsatz von 6,586 Mio. Das Unternehmen konzentriert sich auf die Entwicklung und Vermarktung . (Nasdaq: BIOC), Biocept Aktien News ☑ Mit Realtime Kurs, Dividende und Prognose der Biocept Aktie Analysiere mit wallstreetONLINE Biocept, Inc. 3, 2020 /PRNewswire/ -- Biocept, Inc. Nov 17, 2020, 08:05 ET Biocept Licenses CNSide Liquid Biopsy Assay to Plus Therapeutics Under the agreement, Plus is using the cerebrospinal fluid cell-based assay in its ongoing clinical trial of the radiotherapeutic rhenium SAN DIEGO, Aug. yqine39, c2ty, ov, qmft, bgx, bht, dsww1, iakdp, egja, qbnxp,